<DOC>
	<DOCNO>NCT02502214</DOCNO>
	<brief_summary>Preimplantation Genetic Diagnosis ( PGD ) monogenic disease usually perform multiplex PCR combine polymorphic microsatellites familial analysis , possible , couple-specific mutation detection . Single-cell multiplex PCR development costly time-consuming . We propose test clinically validate target next-generation sequence approach PGD cystic fibrosis . This technique would allow PGD probably almost every couple ask centre , without previous couple-specific development ( preliminary familial analysis ) . It base haplotyping use large number SNPs mutation detection . A clinical validation perform reanalysing non-transferable embryo obtain PGD cystic fibrosis , couple 's informed consent . Concordance result PGD reanalysis NGS achieve validated , technique may apply future PGD cystic fibrosis centre . The technique may apply PGD indication set-up often need .</brief_summary>
	<brief_title>Feasibility Study Preimplantation Genetic Diagnosis Single-gene Disorders</brief_title>
	<detailed_description />
	<criteria>Age &gt; = 18 year Couples risk transmit cystic fibrosis ask PGD Strasbourg DNA sample available laboratory : The couple A related CFTR status know Having sign informed consent Inability give inform consent ( understanding difficulty ... )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Preimplantation Genetic Diagnosis</keyword>
	<keyword>PGD</keyword>
	<keyword>Next-Generation Sequencing</keyword>
	<keyword>NGS</keyword>
	<keyword>Single-Gene disorder</keyword>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>CFTR</keyword>
	<keyword>Single-cell analysis</keyword>
	<keyword>PCR</keyword>
	<keyword>SNP</keyword>
	<keyword>Whole Genome Amplification</keyword>
</DOC>